Clinical Cancer Research
Latest Publications

TOTAL DOCUMENTS

15542
(FIVE YEARS 1404)

H-INDEX

272
(FIVE YEARS 14)

Published By American Association For Cancer Research

1557-3265, 1078-0432
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models

2022 ◽  
pp. clincanres.0947.2021
Author(s):  
Jian L. Campian ◽  
Subhajit Ghosh ◽  
Vaishali Kapoor ◽  
Ran Yan ◽  
Sukrutha Thotala ◽  
...  
Keyword(s):  
T Cells ◽  
Cd8 T Cells ◽  
Interleukin 7 ◽  
Long Acting ◽  
Mouse Glioma

Metabolic alterations and WNT signaling impact immune response in HGSOC

2022 ◽  
pp. clincanres.2984.2021
Author(s):  
Rebecca C. Arend ◽  
Carly B. Scalise ◽  
Emily R. Gordon ◽  
Allison M. Davis ◽  
McKenzie E. Foxall ◽  
...  
Keyword(s):  
Immune Response ◽  
Wnt Signaling ◽  
Metabolic Alterations

Integrated analysis of ovarian juvenile granulosa cell tumors reveals distinct epigenetic signatures and recurrent TERT rearrangements

2022 ◽  
pp. clincanres.3394.2021
Author(s):  
Theodore Vougiouklakis ◽  
Kelsey Zhu ◽  
Varshini Vasudevaraja ◽  
Jonathan Serrano ◽  
Guomiao Shen ◽  
...  
Keyword(s):  
Granulosa Cell ◽  
Integrated Analysis ◽  
Granulosa Cell Tumors ◽  
Epigenetic Signatures

BAMM (BRAF Autophagy and MEK inhibition in Melanoma): A phase I/II trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600-mutant melanoma

2022 ◽  
pp. clincanres.3382.2021
Author(s):  
Janice M. Mehnert ◽  
Tara Mitchell ◽  
Alexander C. Huang ◽  
Tomas S. Aleman ◽  
Benjamin J. Kim ◽  
...  
Keyword(s):  
Phase I ◽  
Mek Inhibition

scholarly journals Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Post-transplant Myeloma Patients

2022 ◽  
pp. clincanres.3420.2021
Author(s):  
Krina K. Patel ◽  
Jatin J. Shah ◽  
Lei Feng ◽  
Hans C. Lee ◽  
Elisabet E. Manasanch ◽  
...  
Keyword(s):  
Maintenance Therapy ◽  
Safety And Efficacy ◽  
Post Transplant

Has the enemy "MET" its match? Subgroup analysis results from VISION study

2022 ◽  
pp. clincanres.4109.2021
Author(s):  
Samuel Rosner ◽  
Alexander I. Spira
Keyword(s):  
Subgroup Analysis
Load More ...
Sign in / Sign up

Export Citation Format

Share Document